Analgesic Benefit of Low‐Dose Foslevodopa/Foscarbidopa Infusion in Advanced Parkinson's Disease: A Non‐Standard Therapeutic Application

Key Points

• The analgesic benefit of low-dose foslevodopa/foscarbidopa infusion stands out in managing symptoms of advanced Parkinson's disease.
• Data indicating significant pain relief are available from the corresponding author upon request.
• Observational analysis on the analgesic application of foslevodopa/foscarbidopa infusion supports alternative treatment pathways.
• Implications suggest this infusion therapy could enhance quality of life, but further studies are needed for validation.